- Issuer ticker
-
HUMA
- Reported as of
-
11 Jun 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
12 Jun 2026, 17:52:30 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ John Philip Bamforth by Dale A. Sander as Attorney-in-Fact
Key filing fact
John Philip Bamforth filed Form 4 for Humacyte, Inc. (HUMA) on 12 Jun 2026.
Key facts
- This page summarizes John Philip Bamforth's Form 4 filing for Humacyte, Inc. (HUMA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2026, 17:52.
Change
- Previous filing in this sequence was filed on 16 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002026341
Primary reporting owner
Bamforth John Philip
- Relationship
-
Director
- Address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
- Signature
- /s/ John Philip Bamforth by Dale A. Sander as Attorney-in-Fact
- Signature date
- 12 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUMA
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- Shares
- +80,000
- Change %
- Price
-
$0.000000*
- Shares after
- 80,000
- Date
- 11 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $1.08
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote